Erwin Goetschi
Roche (Switzerland)(CH)
Publications by Year
Research Areas
Cancer therapeutics and mechanisms, Neuroscience and Neuropharmacology Research, Photochromic and Fluorescence Chemistry, Crystallization and Solubility Studies, Bioactive Compounds and Antitumor Agents
Most-Cited Works
- → A New DNA Gyrase Inhibitor Subclass of the Cyclothialidine Family Based on a Bicyclic Dilactam−Lactone Scaffold. Synthesis and Antibacterial Properties(2011)68 cited
- → Discovery of Balovaptan, a Vasopressin 1a Receptor Antagonist for the Treatment of Autism Spectrum Disorder(2020)62 cited
- → New Antibacterial Agents Derived from the DNA Gyrase Inhibitor Cyclothialidine(2004)55 cited
- → Cyclothialidine and its congeners: A new class of DNA gyrase inhibitors(1993)50 cited
- → Synthesis and characterization of 1,3-dihydro-benzo[b][1,4]diazepin-2-one derivatives: Part 4. In vivo active potent and selective non-competitive metabotropic glutamate receptor 2/3 antagonists(2010)38 cited
- → Synthesis and characterization of 1,3-dihydro-benzo[b][1,4]diazepin-2-one derivatives: Part 3. New potent non-competitive metabotropic glutamate receptor 2/3 antagonists(2008)18 cited
- → New Anti-MRSA and Anti-VRE Carbapenems; Synthesis and Structure-activity Relationships of 1.BETA.-Metyl-2-(thiazol-2-ylthio)carbapenems.(2002)18 cited
- → Synthesis and characterization of 8-ethynyl-1,3-dihydro-benzo[b][1,4]diazepin-2-one derivatives: Part 2. New potent non-competitive metabotropic glutamate receptor 2/3 antagonists(2008)16 cited
- → New anti‐MRSA and anti‐VRE Carbapenems; Synthesis and Structure—Activity Relationships of 1β‐Methyl‐2‐(thiazol‐2‐ylthio)carbapenems.(2003)2 cited
- → Concise Synthesis of Cyclothialidine Analogues (VI) with Ring Sizes from 12 to 15: Novel Macrocyclization Protocol Involving Reductive Thiolation.(2003)1 cited